Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Utility of CAML as Diagnostic for Early Stage Lung Cancer

Utility of CAML as Diagnostic for Early Stage Lung Cancer
Conditions:   Pulmonary Nodule, Multiple;   Pulmonary Nodule, Solitary
Intervention:  
Sponsors:   Fox Chase Cancer Center;   United States Department of Defense;   Creatv Microtech, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 21, 2019 / by / in
Comments